Search details
1.
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.
Lancet
; 400(10361): 1417-1425, 2022 10 22.
Article
in English
| MEDLINE | ID: mdl-36240838
2.
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Lancet
; 400(10359): 1195-1205, 2022 10 08.
Article
in English
| MEDLINE | ID: mdl-36216006
3.
When innovation outpaces regulations: The legal challenges for direct-to-patient supply of investigational medicinal products.
Br J Clin Pharmacol
; 88(3): 1115-1142, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34390022
4.
Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders.
Br J Clin Pharmacol
; 88(3): 1031-1042, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34296777
5.
A systematic review of methods used to conduct decentralised clinical trials.
Br J Clin Pharmacol
; 88(6): 2843-2862, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34961991
6.
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study.
Rheumatol Int
; 42(2): 261-271, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34755204
7.
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
Lancet
; 396(10264): 1745-1757, 2020 11 28.
Article
in English
| MEDLINE | ID: mdl-33181081
8.
Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack.
BMC Med
; 19(1): 24, 2021 02 03.
Article
in English
| MEDLINE | ID: mdl-33530992
9.
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis.
Br J Clin Pharmacol
; 87(3): 1129-1140, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32668021
10.
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysis.
Pharmacoepidemiol Drug Saf
; 30(4): 482-491, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33386650
11.
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands.
Pharmacoepidemiol Drug Saf
; 29(3): 296-305, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31899936
12.
The PREPARE study: benefits of pharmacogenetic testing are unclear.
Lancet
; 401(10391): 1850, 2023 06 03.
Article
in English
| MEDLINE | ID: mdl-37270236
13.
The effect of indapamide vs. bendroflumethiazide for primary hypertension: a systematic review.
Br J Clin Pharmacol
; 85(2): 285-303, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30312512
14.
Does the provision of a DVD-based audio-visual presentation improve recruitment in a clinical trial? A randomised trial of DVD trial invitations.
BMC Med Res Methodol
; 19(1): 24, 2019 01 30.
Article
in English
| MEDLINE | ID: mdl-30700250
15.
The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
Respir Res
; 19(1): 249, 2018 Dec 12.
Article
in English
| MEDLINE | ID: mdl-30541559
16.
Serum uric acid lowering with empagliflozin in heart failure with reduced ejection fraction: a sweet added benefit?
Eur Heart J
; 43(36): 3447-3449, 2022 09 21.
Article
in English
| MEDLINE | ID: mdl-35938377
17.
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
Eur Heart J
; 38(23): 1843-1850, 2017 Jun 14.
Article
in English
| MEDLINE | ID: mdl-27705888
18.
Cardiovascular safety of febuxostat - Authors' reply.
Lancet
; 398(10304): 955-956, 2021 09 11.
Article
in English
| MEDLINE | ID: mdl-34509228
19.
Spironolactone use and risk of incident cancers: a retrospective, matched cohort study.
Br J Clin Pharmacol
; 83(3): 653-663, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27735065
20.
Electronic case report forms and electronic data capture within clinical trials and pharmacoepidemiology.
Br J Clin Pharmacol
; 83(9): 1880-1895, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28276585